Genzyme rejects sanofi offer

Genzyme Corp. (NASDAQ:GENZ) rejected an unsolicited offer it received on Sunday from sanofi-aventis Group (Euronext:SAN; NYSE:SNY) to acquire the biotech for

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE